Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!


GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics, today announced will be added to the Russell 2000® Index effective at the opening of the U.S. equity markets on June 28, 2021. How will this impact the price of GTBP stock?

GT Biopharma to be added to Russell 2000® Index

BEVERLY HILLS, Calif., June 8, 2021 /PRNewswire/ — GT Biopharma, Inc. (“GT Biopharma” or the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company’s proprietary natural killer (NK) cell engager (TriKE™) protein biologic technology platform, today announced that it is set to be added to the Russell 2000® Index at the conclusion of the Russell US Indexes annual reconstitution, effective at the opening of the U.S. equity markets on June 28, 2021.

Related: Thinking about Investing in Cannabis ETFs?

“Our inclusion in the Russell index is an important milestone for us as it reflects the continued progress we are making to develop and commercialize our first-in-class therapeutics. We welcome the enhanced visibility of our long-term growth potential and look forward to sharing our future milestones with a broader investment community,” said Anthony J. Cataldo, GT Biopharma’s Chairman and Chief Executive Officer

GT Biopharma to be added to Russell 2000® Index

FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. Membership in the small-cap Russell 2000® Index, which remains in place for one year, is based on membership in the broad-market Russell 3000Ò Index.

Related: Vitality Biopharma Pursues CBD Drug Treating Severe GI Issues

Russell’s U.S. indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $9 trillion in assets are benchmarked against Russell’s U.S. indexes. Russell Indexes are part of FTSE Russell, a leading global index provider.

For more information about the Russell U.S. Indexes and the Russell Indexes reconstitution, visit the FTSE Russell website.

Nextleaf Solutions Provides Q2 Update

About GT Biopharma, Inc.
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based on our proprietary TriKE™ NK cell engager platform.  Our TriKE™ platform is designed to harness and enhance the cancer killing abilities of a patient’s immune system’s natural killer cells (NK cells).  GT Biopharma has an exclusive worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE™ technology. For more information, please visit gtbiopharma.com.

Related: GT Biopharma

Investor Contact:

Brendan Payne

Client Lead

Stern Investor Relations, Inc.

[email protected] 

212-362-1200

 

Investor and Media Relations Contact:

David Castaneda

[email protected]

414-351-9758

GT Biopharma to be added to Russell 2000® Index


Cannin Investment Group: Your Hemp Stocks Experts

Hemp Stocks Algorithm

Cannin.com is your trusted resource for top hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best hemp stocks for 2021. 

Use Cannin as your resource for:

Is it too late to invest in hemp stocks? No! This is the perfect time to invest.

Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now. 

Are you interested in the best hemp stocks for 2021 like HempFusion, Inc., Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Are you looking to buy stock in hemp companies or stock in cannabis companies in 2021? Interested in penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks? We can help.

Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +30% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012

At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best hemp stocks – we’ll show you how at cannin.com.